These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26702838)

  • 21. Comparison of rhBMP-2 versus Autogenous Iliac Crest Bone Graft for 2-Level Anterior Cervical Discectomy and Fusion for Cervical Spondylotic Myelopathy.
    Tan B; Wang H; Dong J; Yuan Z; Wang D; Wang F
    Med Sci Monit; 2015 Oct; 21():3159-65. PubMed ID: 26479708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posterior Cervical Fusion With Recombinant Human Bone Morphogenetic Protein-2: Complications and Fusion Rate at Minimum 2-Year Follow-Up.
    Dorward IG; Buchowski JM; Stoker GE; Zebala LP
    Clin Spine Surg; 2016 Jul; 29(6):E276-81. PubMed ID: 27137152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Recombinant Human Bone Morphogenetic Protein-2 With Iliac Crest Bone Graft Instead of Iliac Crest Bone Graft Alone in Lumbar Spondylolysis.
    Meng H; Gao Y; Zhao G; Sun T; Li F
    Clin Spine Surg; 2022 Mar; 35(2):E314-E319. PubMed ID: 34654776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
    Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
    Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials.
    Chen Z; Ba G; Shen T; Fu Q
    Arch Orthop Trauma Surg; 2012 Dec; 132(12):1725-40. PubMed ID: 22941273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion.
    Carragee EJ; Bono CM; Scuderi GJ
    Spine J; 2009 Nov; 9(11):873-9. PubMed ID: 19850231
    [No Abstract]   [Full Text] [Related]  

  • 29. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
    Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomic feasibility of a new endopelvic approach for iliac crest bone harvesting.
    Le Pape S; Du Pouget L; Cloche T; Campana M; Obeid I; Boissiere L; Vital JM
    Surg Radiol Anat; 2016 Dec; 38(10):1191-1194. PubMed ID: 27160584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery.
    Burkus JK; Sandhu HS; Gornet MF; Longley MC
    J Bone Joint Surg Am; 2005 Jun; 87(6):1205-12. PubMed ID: 15930528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Clinical Effectiveness and Safety of Bone Morphogenetic Protein Versus Autologous Iliac Crest Bone Graft in Lumbar Fusion: A Meta-analysis and Systematic Review.
    Liu S; Wang Y; Liang Z; Zhou M; Chen C
    Spine (Phila Pa 1976); 2020 Jun; 45(12):E729-E741. PubMed ID: 31923133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
    Glassman SD; Dimar JR; Carreon LY; Campbell MJ; Puno RM; Johnson JR
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1694-8. PubMed ID: 16094268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
    Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
    Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
    J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Mummaneni PV; Pan J; Haid RW; Rodts GE
    J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
    Park DK; Kim SS; Thakur N; Boden SD
    Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.